The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

Five years after the last prostatic carcinoma grading consensus conference of the International Society of Urological Pathology (ISUP), accrual of new data and modification of clinical practice require an update of current pathologic grading guidelines. This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France. Topics brought to consensus included the following: (1) approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns, (2) an agreement to report the presence of invasive cribriform carcinoma, (3) an agreement to incorporate intraductal carcinoma into grading, and (4) individual versus aggregate grading of systematic and multiparametric magnetic resonance imaging-targeted biopsies. Finally, developments in the field of artificial intelligence in the grading of prostatic carcinoma and future research perspectives were discussed.

[1]  C. Pan,et al.  The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. , 2000, The American journal of surgical pathology.

[2]  J. Epstein,et al.  Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. , 2000, The American journal of surgical pathology.

[3]  J. Epstein,et al.  Mucinous adenocarcinoma of the prostate gland. , 2014, The Ceylon medical journal.

[4]  J. Epstein,et al.  Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. , 1999, The American journal of surgical pathology.

[5]  C. H. Neuswanger,et al.  Urology , 1939, The Yale Journal of Biology and Medicine.

[6]  R. Zarbo,et al.  Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. , 1994, Archives of pathology & laboratory medicine.

[7]  J. McNeal,et al.  Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. , 1996, The American journal of surgical pathology.

[8]  D. Gleason.  Classification of prostatic carcinomas. , 1966, Cancer chemotherapy reports.

[9]  Sten Nilsson,et al.  Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens , 2005, Scandinavian journal of urology and nephrology. Supplementum.

[10]  T. Stamey,et al.  Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.

[11]  A W Partin,et al.  Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. , 2000, Urology.

[12]  M. Kattan,et al.  Predicting clinical end points: treatment nomograms in prostate cancer. , 2003, Seminars in oncology.

[13]  Gleason Df.  Classification of prostatic carcinomas. , 1966 .

[14]  S. Piantadosi,et al.  Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.

[15]  D. Bostwick,et al.  Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding. , 1995, Archives of pathology & laboratory medicine.

[16]  J. Epstein,et al.  Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy. , 1999, Urology.

[17]  M. Rubin,et al.  Prostate Needle Biopsy Reporting: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide Treatment of Prostate Cancer Patients? , 2004, The American journal of surgical pathology.

[18]  Lars Egevad,et al.  Current practice of Gleason grading among genitourinary pathologists. , 2005, Human pathology.

[19]  J. Epstein,et al.  Evaluation of Radical Prostatectomy Specimens: A Comparative Analysis of Sampling Methods , 1992, The American journal of surgical pathology.

[20]  J. Epstein,et al.  Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance , 2006, Modern Pathology.

[21]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[22]  J. Epstein,et al.  Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. , 2000, The American journal of surgical pathology.

[23]  Ximing J. Yang,et al.  Prostatic Foamy Gland Carcinoma With Aggressive Behavior: Clinicopathologic, Immunohistochemical, and Ultrastructural Analysis , 2001, The American journal of surgical pathology.

[24]  J. Epstein,et al.  Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. , 1996, The American journal of surgical pathology.

[25]  T. Stamey,et al.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.

[26]  J. Bailar,et al.  The histology and prognosis of prostatic cancer. , 1967, The Journal of urology.

[27]  J. Epstein,et al.  Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy. , 1999, The American journal of surgical pathology.

[28]  M. Banerjee,et al.  Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. , 2000, Urology.

[29]  P. Humphrey,et al.  Pseudohyperplastic prostatic adenocarcinoma. , 1998, The American journal of surgical pathology.

[30]  Liang Cheng,et al.  Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites , 2005, Modern Pathology.

[31]  J C Bailar,et al.  Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report. , 1966, Cancer chemotherapy reports.

[32]  T. Tsuzuki,et al.  The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens , 2004, The American journal of surgical pathology.

[33]  D. Page,et al.  Prostatic adenocarcinoma with glomeruloid features. , 1999, Human pathology.

[34]  C. Busch,et al.  Morphometric studies of intra-prostatic volume relationships in localized prostatic cancer. , 1997, British journal of urology.

[35]  H. Schröder,et al.  [Prognosis of the prostatic carcinoma]. , 1969, Bruns' Beitrage fur klinische Chirurgie.

[36]  P. Humphrey,et al.  Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens , 2005, Scandinavian journal of urology and nephrology. Supplementum.

[37]  M. Rubin,et al.  Should a Gleason Score Be Assigned to a Minute Focus of Carcinoma on Prostate Biopsy? , 2000, The American journal of surgical pathology.

[38]  Lang Li,et al.  Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate , 2004, Cancer.

[39]  Gleason Df,et al.  Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report. , 1966 .

[40]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[41]  M. Cohen,et al.  Sampling of radical prostatectomy specimens. How much is adequate? , 1994, American journal of clinical pathology.

[42]  R. Cohen,et al.  Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma. , 1998, British journal of urology.

[43]  C. Pan,et al.  Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. , 2001, Human pathology.

[44]  J. Epstein,et al.  Should each core with prostate cancer be assigned a separate gleason score? , 2003, Human pathology.

[45]  D. Grignon,et al.  Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies. , 1990, Human pathology.